Literature DB >> 14742805

Point-of-care testing: an introduction.

Sheryl L Gutierres1, Timothy E Welty.   

Abstract

OBJECTIVE: To review available literature and provide perspective on point-of-care testing, focusing on the impact it has on treatment outcomes in patient care, the impact it has on the costs of patient care, and the role it has in the delivery of pharmaceutical care. DATA SOURCES: Information was retrieved from MEDLINE English literature searches using PubMed (1965-August 2003) and included search terms of point-of-care testing, near patient testing, pharmaceutical care, pharmacists, outcomes, and economics. Additionally, references from retrieved articles were reviewed to identify literature not detected by literature searches. STUDY SELECTION AND DATA EXTRACTION: Comparative studies, demonstration project reports, and systematic reviews were selected. Other related resources, such as government documents, relevant legislation, and government regulations, were included. Emphasis was placed on comparative studies and demonstration project reports. In the absence of these data, other resources were included. DATA SYNTHESIS: Point-of-care testing devices and technology are increasingly used in the delivery of care and therapeutic decision making. No studies have evaluated the impact of point-of-care testing, by itself, on patient care and outcomes. All studies have incorporated point-of-care testing with changes in the way patient care is delivered and have shown significant improvements when this approach is taken. The cost of point-of-care testing is greater than traditional laboratory testing, but the increased cost may be offset by improvements in the management of patient care, improvements in patient outcomes, and decreased utilization of the healthcare system. Point-of-care testing has been used successfully by pharmacists in disease management programs. Various government regulations and legislation impact the use of point-of-care testing.
CONCLUSIONS: Limited data indicate that point-of-care testing, when combined with changes in healthcare delivery systems, may improve patient outcomes and decrease the overall cost of health care. Pharmacists have used point-of-care testing in programs designed to improve patient care but must carefully consider regulations and laws that govern the use of these devices. There is a great need for additional investigation into the use of point-of-care testing in patient care.

Entities:  

Mesh:

Year:  2004        PMID: 14742805     DOI: 10.1345/aph.1D212

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  10 in total

1.  Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Piya Chaemsaithong; Roberto Romero; Nikolina Docheva; Noppadol Chaiyasit; Gaurav Bhatti; Percy Pacora; Sonia S Hassan; Lami Yeo; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

Review 2.  The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.

Authors:  R Romero; J Espinoza; F Gotsch; J P Kusanovic; L A Friel; O Erez; S Mazaki-Tovi; N G Than; S Hassan; G Tromp
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

3.  Hemoglobin test result variability and cost analysis of eight different analyzers during open heart surgery.

Authors:  Kirti P Patel; Gary W Hay; Mahesh Keitheri Cheteri; David W Holt
Journal:  J Extra Corpor Technol       Date:  2007-03

4.  A point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Yeon Mee Kim; Bo Hyun Yoon; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-20

Review 5.  Point-of-care nucleic acid testing for infectious diseases.

Authors:  Angelika Niemz; Tanya M Ferguson; David S Boyle
Journal:  Trends Biotechnol       Date:  2011-03-04       Impact factor: 19.536

6.  An elective course on pharmacy-based health screenings.

Authors:  Erin C Raney
Journal:  Am J Pharm Educ       Date:  2013-08-12       Impact factor: 2.047

7.  Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment.

Authors:  Heather P Whitley; Joli D Fermo; Kelly Ragucci; Elinor C Chumney
Journal:  Pharm Pract (Granada)       Date:  2006-12-12

Review 8.  PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings.

Authors:  Samuel Yang; Richard E Rothman
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

9.  Is point-of-care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of a point-of-care polymerase chain reaction test for SARS-CoV-2.

Authors:  Massimo Micocci; Adam L Gordon; Mikyung Kelly Seo; A Joy Allen; Kerrie Davies; Dan Lasserson; Carl Thompson; Karen Spilsbury; Cyd Akrill; Ros Heath; Anita Astle; Claire Sharpe; Rafael Perera; Gail Hayward; Peter Buckle
Journal:  Age Ageing       Date:  2021-09-11       Impact factor: 10.668

10.  Impact of point-of-care panel tests in ambulatory care: a systematic review and meta-analysis.

Authors:  Clare Goyder; Pui San Tan; Jan Verbakel; Thanusha Ananthakumar; Joseph J Lee; Gail Hayward; Philip J Turner; Ann Van Den Bruel
Journal:  BMJ Open       Date:  2020-02-27       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.